In Vitro Activities of Gemifloxacin (SB 265805, LB20304) against Recent Clinical Isolates of Chlamydia pneumoniae
We compared the in vitro activity of gemifloxacin, a new quinolone antibiotic, to the activities of levofloxacin, moxifloxacin, trovafloxacin, erythromycin, and doxycycline against 20 isolates of Chlamydia pneumoniae. Gemifloxacin was the most active quinolone tested, with a MIC at which 90% of the...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1999
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC89566/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10543770/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.43.11.2806 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|